GMVDW
Income statement / Annual
Last year (2022), G Medical Innovations Holdings Ltd's total revenue was $4.42 M,
a decrease of 12.61% from the previous year.
In 2022, G Medical Innovations Holdings Ltd's net income was -$13.96 M.
See G Medical Innovations Holdings Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$4.42 M |
$5.06 M |
$4.90 M |
$5.53 M |
$3.06 M |
$109.00 K |
| Cost of Revenue |
$3.64 M
|
$3.56 M
|
$4.23 M
|
$5.75 M
|
$4.03 M
|
$1.16 M
|
| Gross Profit |
$784.00 K
|
$1.50 M
|
$667.00 K
|
-$223.00 K
|
-$969.00 K
|
-$1.05 M
|
| Gross Profit Ratio |
0.18
|
0.3
|
0.14
|
-0.04
|
-0.32
|
-9.6
|
| Research and Development Expenses |
$2.29 M
|
$1.68 M
|
$1.32 M
|
$2.55 M
|
$243.00 K
|
$186.00 K
|
| General & Administrative Expenses |
$24.86 M
|
$9.01 M
|
$7.66 M
|
$10.00 M
|
$12.61 M
|
$24.01 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$664.00 K
|
$356.00 K
|
| Selling, General & Administrative Expenses |
$24.86 M
|
$9.01 M
|
$7.66 M
|
$10.00 M
|
$13.27 M
|
$24.36 M
|
| Other Expenses |
$1.05 M
|
$854.00 K
|
$3.70 M
|
$0.00
|
$2.70 M
|
$0.00
|
| Operating Expenses |
$28.19 M
|
$11.54 M
|
$12.67 M
|
$12.56 M
|
$16.22 M
|
$25.48 M
|
| Cost And Expenses |
$31.83 M
|
$15.10 M
|
$16.90 M
|
$18.31 M
|
$28.69 M
|
$26.63 M
|
| Interest Income |
$0.00
|
$870.00 K
|
$344.00 K
|
$263.00 K
|
$858.00 K
|
$282.00 K
|
| Interest Expense |
$0.00
|
$4.49 M
|
$750.00 K
|
$3.85 M
|
$995.00 K
|
$923.00 K
|
| Depreciation & Amortization |
-$10.34 M
|
$1.00 M
|
$3.61 M
|
$2.01 M
|
$2.61 M
|
$176.00 K
|
| EBITDA |
-$37.75 M |
-$9.04 M |
-$8.40 M |
-$12.52 M |
-$13.71 M |
-$26.06 M |
| EBITDA Ratio |
-8.54
|
-1.79
|
-1.71
|
-2.26
|
-4.48
|
-239.11
|
| Operating Income Ratio |
-6.2
|
-1.98
|
-2.45
|
-2.63
|
-5.33
|
-240.72
|
| Total Other Income/Expenses Net |
$13.47 M
|
-$3.62 M
|
-$702.00 K
|
-$3.58 M
|
-$137.00 K
|
-$923.00 K
|
| Income Before Tax |
-$13.94 M
|
-$14.89 M
|
-$12.71 M
|
-$16.36 M
|
-$17.32 M
|
-$27.16 M
|
| Income Before Tax Ratio |
-3.15
|
-2.94
|
-2.59
|
-2.96
|
-5.66
|
-249.19
|
| Income Tax Expense |
$16.00 K
|
-$3.00 K
|
-$18.00 K
|
-$857.00 K
|
-$345.00 K
|
$85.00 K
|
| Net Income |
-$13.96 M
|
-$14.89 M
|
-$12.69 M
|
-$15.51 M
|
-$16.98 M
|
-$27.25 M
|
| Net Income Ratio |
-3.16
|
-2.94
|
-2.59
|
-2.81
|
-5.54
|
-249.97
|
| EPS |
0 |
-45.89 |
-60.4 |
-7 |
-8.6 |
-20.39 |
| EPS Diluted |
0 |
-45.89 |
-60.4 |
-7 |
-8.6 |
-20.39 |
| Weighted Average Shares Out |
$0.00
|
$324.45 K
|
$210.07 K
|
$2.21 M
|
$1.97 M
|
$1.34 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$324.45 K
|
$210.07 K
|
$2.21 M
|
$1.97 M
|
$1.34 M
|
| Link |
|
|
|
|
|
|
